Revolutionizing the Treatment of Autoimmune Diseases
Our Vision
Addressing significant unmet needs in the field of autoimmunity through the development of novel patented therapies for treatment of disease.
Pipeline
AnTolRx’s vision is to build a platform that selectively targets pathogenic immune cells providing a unique tolerogenic signal to induce an anti-inflammatory phenotype and better treat diseases.
World Psoriasis Day – October 29!
Psoriasis is an autoimmune disease that affects over 125 million people worldwide, that is up to 3% of the total population! At AnTolRx, our targeted approach actively promotes immune tolerance by inducing an anti-inflammatory phenotype and thus better treat disease....